Skip to main content

Antidepressant Medications and Nursing Considerations

An overview of various classes of antidepressant medications, including SSRIs, SNRIs, TCAs, and MAOIs, detailing their mechanisms of action, indications, adverse effects, and crucial nursing considerations for safe patient management.

Save this reading to your study set

Sign up free

Managing mental health disorders such as Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and Post-Traumatic Stress Disorder (PTSD) often requires pharmacological intervention. For nurses, understanding the nuances of different antidepressant classes is critical, as these medications carry significant risks ranging from metabolic changes to life-threatening hypertensive crises.

Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs are often the first line of defense in treating depressive and anxiety-related conditions.

Mechanism and Indications

SSRIs work by inhibiting the reuptake of serotonin, which increases the availability and signaling of this neurotransmitter in the brain. They are indicated for the management of MDD, GAD, OCD, PTSD, and panic disorder. Common examples include Citalopram, Escitalopram, Fluoxetine, Paroxetine, and Sertraline.

Adverse Effects and Nursing Considerations

Common side effects include nausea, diarrhea, headache, sleep changes, and sexual dysfunction.

When caring for a patient on SSRIs, nurses must prioritize the following:

  • Suicidal Ideation: Always assess for increased suicidal thoughts, especially when starting therapy or changing doses.
  • Serotonin Syndrome: Monitor for signs of toxicity, including agitation, confusion, sweating, fever, diarrhea, tremors, and muscle rigidity.
  • Electrolytes: Monitor sodium levels.

Patient Teaching Tip: Inform patients that it can take 4 to 6 weeks to achieve the full therapeutic effect. Advise them to take the medication with food to minimize nausea and in the morning to prevent sleep disturbances.

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

SNRIs offer a dual-action approach to neurotransmitter management.

Mechanism and Indications

SNRIs inhibit the reuptake of both serotonin and norepinephrine. They are used for depression and anxiety disorders, and specifically, Duloxetine is also approved for certain chronic pain conditions. Common agents include Venlafaxine, Duloxetine, and Desvenlafaxine.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.